Sebastian Garrido Lecca
About Sebastian Garrido Lecca
Sebastian Garrido Lecca is the WW Medical Associate Director for Genitourinary Tumors at Bristol Myers Squibb and a One Young World 2017 Ambassador.
Title
Sebastian Garrido Lecca currently holds the position of WW Medical Associate Director Genitourinary Tumors at Bristol Myers Squibb in the United States. In this role, he focuses on advancing the medical strategies and research associated with genitourinary tumors.
Company
Sebastian Garrido Lecca works at Bristol Myers Squibb, a global biopharmaceutical company. He has been with the company in various capacities, including current roles and past positions such as Associate Director, Access Scientific Content Oncology, and Health Economics and Outcomes Research / Medical Information Manager for Middle East Africa & India.
Education and Expertise
Sebastian holds a Doctor of Medicine (MD) degree from Universidad de San Martín de Porres, a Master of Business Administration (MBA) focusing on Health Care Administration/Management from Universidad Peruana de Ciencias Aplicadas, and a Master’s in Health Economics and Pharmacoeconomics from Universitat Pompeu Fabra. He has also completed specialized courses in health technology assessment, pharmacoeconomics, and project management from reputable institutions.
Background
Sebastian Garrido Lecca has an extensive international background in the healthcare sector, having worked in diverse regions such as the United States, United Arab Emirates, and Peru. His career includes roles in clinical site monitoring, health outcomes research, and scientific advisement, demonstrating a strong track record in oncology and health economics.
Achievements
Sebastian has been an ambassador for One Young World since 2017, highlighting his commitment to global leadership and development. He has also progressed through various significant roles at Bristol Myers Squibb, indicating his impact and experience within the company. His work spans across crucial projects in clinical research and health economics, contributing extensively to the oncology field.